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Introduction: Several growth factors (GFs) participate in the regulation
of cell proliferation, migration, differentiation and apoptosis. GFs such
as VEGF-A and FGF-b are essential to trigger the angiogenic cascade
that is crucial for the subsequent steps of new tissue formation.1
Human Platelet’s lysate (hPL) has been used as an autologous source of
GFs.2 Herein, we investigated whether marine-origin polysaccharides
are able to attract and stabilize pro-angiogenic GFs from PL and acti-
vate endothelial cells by providing pro-angiogenic cues.
Materials and methods: j-, ι-, k-carrageenan (Car), alginate, chitosan
and heparin were purchased from Sigma-Aldrich. Human PL was
obtained as described elsewhere3. The interaction of mentioned the
polyelectrolytes (PEs) with PL was assessed by QCM-D (Q-sense). The
thickness of the nanocoatings was measured by ellipsometry and
VEGF-A and FGF-b binding quantiﬁed by ELISA (Peportech). Human
umbilical vein endothelial cells (HUVECs) were cultured in M199 cul-
ture media supplemented with 20%FBS and ECGS. Cells were seeded
on 48-well-plates previously modiﬁed with the nanocoatings prepared
by Layer-by-Layer assembling, i.e. by the alternating deposition of each
of the mentioned PE with diluted PL (1, 3 and 6 bilayers), in the
absence of ECGS and with 10% serum. The effect of the VEGF-A and
bFGF on HUVECs was assessed in cultures established with 150 or
200 nM of FGF/VEGF Receptor Tyrosine Kinase Inhibitor (Santa Cruz
Biotechnology).
Results: The thickness of nanocoatings varied between 30 and 45 and
the GFs binding was quantiﬁed. The more sulfated PE’s, heparin/PL
and k-Car/PL, were able to induce the formation of tube-like structures
after 20 hours of culture (Figure 1). An increase of tube-length was
observed with increasing number of bilayers. When the binding of the
angiogenic GFs to the VEGF/FGF receptors is inhibited, the formation
of tube-like structures is reduced or does not occur, depending on the
concentration of the inhibitor.
Figure 1. HUVECs cell morphology after 20 hours (blue-nucleus,
orange-cytoskeleton) on k-Car/PL coatings in absence (left) or presence
of 150 nM (middle) and 200 nM (right) of inhibitor.
The cells were able to proliferate on the nanocoatings that have
induced tube-like structures formation, especially on ι-carrageenan/PL.
However with proliferation slowed down in absence of ECGS, tube-like
structures can be observed after 4 days in culture.
Discussion and conclusions: Nanocoatings composed by sulfated
marine-origin polysaccharides and hPL bio-activate endothelial cells
inducing the formation of tube-like structures. The formation of the
tube-like structures, which depended on the PE and number of bilayers,
was achieved after 20 hours of incubation and was mediated by the
VEGF/FGF. The combination of hPL with these PEs may be an efﬁcient
and simple method to introduce pro-angiogenic cues in any 2D/3D
cell-material interface and improve tissue regeneration.
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Introduction: Development of bioactive microcarriers that allow 3D
culture of stem cells is important for bone tissue engineering. Aim is to
engineer microcarriers with bioactive composition and growth fac-
tor-delivering capacity which is ultimately effective for osteogenesis of
stem cells and bone regeneration. We propose a novel bioactive micro-
carrier composed of silica-based bioactive glass which is produced by a
sol-gel process.
Materials and methods: The microcarriers were prepared by water in
oil emulsion, taking advantage of the sol-gel reaction of tetraethyl
orthosilicate. Microcarriers were doped with different calcium ions from
0 to 30. Speciﬁc surface area, pore size and zeta potential were mea-
sured. Model protein was encapsulated in two different compositions to
observe calcium effect on release proﬁle. In vitro bioactivity was per-
formed immersing samples in SBF. The biocompatibility was deter-
mined in vitro and in vivo. Basic Fibroblast Growth Factor (bFGF) was
encapsulated within the microcarriers and the effects on cell prolifera-
tion were analyzed.
Results: Highly mesoporous structure was created with mesopore sizes
of 2.5~6.3 nm and speciﬁc surface area of 420~710 m2/g, which was
highly dependent on the Ca concentration. Cyt C proﬁled an almost
zero-order kinetics presenting slight increase in release rate, presum-
ably due to the larger pore size. The presence of Ca accelerated the for-
mation of apatite on the surface of the microcarriers. Cells cultured on
the bioactive microcarriers adhered and spread well and proliferated
actively. In vivo study showed the tissue compatibility of the microcarri-
ers. Near zero order kinetics with releasing period of over a month was
shown for bFGF release. Cells adhered and proliferated to signiﬁcantly
higher degree on the bFGF-loading samples, demonstrating an effective
role of bFGF released from the microcarriers.
Discussion and conclusions: Bioactive silica-based sol-gel derived micro-
carriers demonstrated high mesoporosity with tunable pore size and
volume and surface area. They also had self-hardening ability to safely
incorporate biological molecules with long-term delivery over months,
and showed excellent biocompatibility to enable cell growth and tissue
reactions. Based on these, the microcarriers may be potentially useful
for bone tissue engineering.
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